Healthcare / Private Equity Investment
Healthcare / Private Equity Investment
Company Valuation7.7 billion
Company Valuation
7.7 billion
Wolwo Bio-Pharmaceutical focuses on drug innovation, and has the world leading bio-pharmaceutical technology. It is the biggest R&D center of allergen drugs in Asia and the biggest manufacturer of desensitization drugs in China. Started from the respiratory allergy therapies which has the strongest demand, relying on international standard and experienced professional team, supported by the world-leading and intellectual property protected allergen drugs technology platform, Wolwo will continue to research and develop various kinds of desensitization drugs and diagnostic reagent.
分享到：